Position in CRON
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$597,651
-$2,359,084 QoQ
Shares Held
238,108
-78.8% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $750,878,580 across 46 Drug Manufacturers - Specialty & Generic names. CRON ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,060,570 | $403,199,491 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,392,628 | $60,857,818 | |
| 3 | ALKS |
Alkermes plc.
|
780,683 | $27,604,950 | |
| 4 | ESPR |
Esperion Therapeutics, Inc.
|
9,458,779 | $25,917,054 | |
| 5 | LQDA |
Liquidia Corp
|
563,233 | $21,256,413 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
5,848,276 | $20,527,448 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
420,914 | $20,267,009 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
590,116 | $19,515,136 |
All Filings in CRON
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $597,651 | 238,108 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,956,735 | 1,124,234 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,642,873 | 1,310,386 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $759,440 | 397,613 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $681,812 | 376,692 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,291,140 | 1,134,228 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,210,369 | 1,465,922 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,128,090 | 2,200,897 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,057,884 | 1,554,745 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,158,907 | 554,501 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $102,264 | 51,132 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $829,769 | 326,681 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,085,398 | 739,503 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,241,287 | 440,173 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,544,583 | 911,204 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $454,014 | 115,820 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,708,174 | 478,476 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $16,688,033 | 1,940,469 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,613,965 | 382,026 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||